Compounds > c.i. 42510
Page last updated: 2024-08-21

c.i. 42510 and Endophthalmitis

c.i. 42510 has been researched along with Endophthalmitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, S; Mukkamala, SK; Whittier, S1
Adams, E; Arroyo, S; Duran, J; Grant-Greene, Y; Harris, JR; Kim, M; Lee, EH; Lockhart, SR; Mascola, L; Mikosz, CA; Park, BJ; Robinson, BF; Smith, RM; Sowadsky, R; Straif-Bourgeois, S; Török, TJ; Tyson, C; Vasquez, Y1

Other Studies

3 other study(ies) available for c.i. 42510 and Endophthalmitis

ArticleYear
Microfiltration of brilliant blue G dye.
    Retina (Philadelphia, Pa.), 2013, Volume: 33, Issue:5

    Topics: Bacteria; Colony Count, Microbial; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Filtration; Fungi; Humans; Indicators and Reagents; Models, Biological; Rosaniline Dyes

2013
Fungal endophthalmitis associated with compounded products.
    Emerging infectious diseases, 2014, Volume: 20, Issue:2

    Topics: Aged; Aged, 80 and over; Blindness; Drug Recalls; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Male; Middle Aged; Ophthalmic Solutions; Retina; Rosaniline Dyes; Saccharomycetales; Triamcinolone Acetonide; United States; Vitreous Body

2014
Notes from the field: Multistate outbreak of postprocedural fungal endophthalmitis associated with a single compounding pharmacy - United States, March-April 2012.
    MMWR. Morbidity and mortality weekly report, 2012, May-04, Volume: 61, Issue:17

    Topics: Ascomycota; Disease Outbreaks; Drug Compounding; Drug Contamination; Drug Labeling; Endophthalmitis; Fusariosis; Fusarium; Humans; Indicators and Reagents; Ophthalmologic Surgical Procedures; Pharmacies; Rosaniline Dyes; United States; Vitrectomy

2012